Michelle L. Basil, EVP and General Counsel at HAEMONETICS CORP (HAE), sold 46,931 shares at $87.71 ($4.2M) on 2020-06-15, disclosed to the SEC on 2020-06-16.
Seasonal sale ($4.2M) by EVP and General Counsel — this insider has traded HAE in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.29 | 203 | $18K | 0.4% |
| 2 | $87.71 | 10,578 | $928K | 22.1% |
| 3 | $87.71 | 10,578 | $928K | 22.1% |
| 4 | $90.32 | 5,175 | $467K | 11.1% |
| 5 | $90.32 | 5,175 | $467K | 11.1% |
| 6 | $91.34 | 6,961 |
| $636K |
| 15.1% |
| 7 | $91.34 | 6,961 | $636K | 15.1% |
| 8 | $92.14 | 1,300 | $120K | 2.9% |
| Total | $89.49 avg | 46,931 | $4.2M | 100% |
| Filing → |
| HAE | SELL | 2024-05-17 | $189K | — | Filing → |
| HAE | SELL | 2022-10-26 | $14K | — | Filing → |
| HAE | SELL | 2022-09-21 | $1.8M | — | Filing → |